Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Targeting the AhR pathway may help treat alopecia areata.

KX-826 is safe and effectively increases hair count in men with hair loss.

The new wound dressing with minoxidil and dexamethasone could speed up healing and reduce scarring in rats.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Epiregulin can help hair grow and may be useful for treating hair loss.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Drug repurposing offers a faster, cheaper way to find treatments for rare diseases.

Analog 23 is a promising compound for prostate cancer treatment.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

MC-1R is present in skin cells and may help reduce inflammation.

A new compound was effective for imaging prostate cancer in rats.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

BMS-470539 reduces skin fibrosis and inflammation.

Vitamin D receptor is crucial for bone health and mineral metabolism.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Low-dose naltrexone might be a cheap and effective additional treatment for hair loss with scalp discomfort due to its anti-inflammatory effects and few side effects.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

ocu-miR-205 affects hair density in Rex rabbits by altering hair follicle growth and signaling pathways.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

CRH promotes fat production in skin cells, affecting conditions like acne.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.